Cornerstone Pharmaceuticals, Inc

Cranbury, New Jersey 08512

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)

Studies at this site

• Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome — Withdrawn before enrolling